Published in
American Association for the Advancement of Science, Science Immunology, 32(4), 2019
DOI: 10.1126/sciimmunol.aav5062
Links
Tools
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes
Journal article published in 2019 by
Julie M. Fox 
,
Vicky Roy ,
Bronwyn M. Gunn ,
Ling Huang,
Melissa A. Edeling ,
Matthias Mack,
Daved H. Fremont ,
Benjamin J. Doranz,
Syd Johnson,
Galit Alter,
Michael S. Diamond
,
Vicky Roy ,
Bronwyn M. Gunn ,
Ling Huang,
Melissa A. Edeling ,
Matthias Mack,
Daved H. Fremont ,
Benjamin J. Doranz,
Syd Johnson,
Galit Alter,
Michael S. Diamond
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Anti–chikungunya virus antibodies require FcγR engagement but not complement activation for protection and viral clearance.